Pharmafile Logo
Pharmafocus logo
Advanced Search

Johnson & Johnson working on coronavirus vaccine

January 30, 2020
Business Services, Research and Development Chinese Coronavirus, Wuhan Coronavirus, Wuhan epidemic, coronavirus

Johnson & Johnson has become the latest pharmaceutical company to begin work on a vaccine for the Chinese coronavirus. They …

News
logo-24-allergan

Allergan opens new Botox plant in Westport

January 29, 2020
Research and Development AbbVie Ireland, Allergan AbbVie, Allergan. Abbvie

Allergan has officially opened a new €145m facility in Westport, Ireland to boost production of Botox. The new building rxpands …

News
janssen_latest_logo_on_sign_closer

Janssen’s Erleada expanded in Europe to cover metastatic hormone-sensitive prostate cancer

January 29, 2020
Research and Development, Sales and Marketing Erleada, Europe, Janssen, pharma

Janssen’s Erleada (apalutamide) has secured expanded authorisation from the European Commission (EC), approving its label to include the treatment of …

News

BioIntelliSense’ BioSticker sensor approved by the FDA

January 29, 2020
Research and Development Biosticker, home care, sensors

BioIntelliSense has secured 510 (k) clearance from the FDA for its biosticker sensor for remote care. The product is an …

News
teva_copy

FDA approves Teva’s Ajovy autoinjector for treatment of migraine

January 29, 2020
Research and Development, Sales and Marketing FDA, Teva, ajovy, migraine, pharma

Israeli pharma firm Teva has revealed that the FDA has chosen to award approval to its autoinjector device for the …

News
british-2746299_960_720

British Airways suspends all flights to mainland China

January 29, 2020
Research and Development British Airways, MERS, Sars, Wuhan Virus, coronavirus, virus

British Airways has ceased all flights to mainland China until 31 January. This comes after the Foreign Office advice against …

News

Prostate Cancer becomes most commonly diagnosed cancer in England

January 28, 2020
Manufacturing and Production Cancer, Cancer diagnoses, NHS England, breast cancer, prostate cancer

Prostate cancer has overtaken breast cancer to be the most commonly diagnosed cancer for the first time in England, latest …

News
shutterstock_243110086

Lilly & Incyte’s Olumiant hits main goal in atopic dermatitis

January 28, 2020
Manufacturing and Production, Research and Development Eli Lilly, Olumiant, pharma

Eli Lilly and Incyte have lifted the curtain on new Phase 3 data showing that their oral JAK inhibitor, showing …

News

Johnson & Johnson CEO testifies for the first time in Baby Powder Cancer trial

January 28, 2020
Manufacturing and Production J&J, JJ, Johnson & Johnson, Talc Powder Cancer, baby powder, talc powder

Johnson & Johnson CEO Alex Gorsky faced questions around stock sales and his knowledge of asbestos in the company’s baby …

News
janssen_latest_logo_on_sign

NICE rejects Janssen’s esketamine nasal spray Spravato for treatment-resistant depression

January 28, 2020
Manufacturing and Production, Sales and Marketing Janssen, NHS, NICE, Spravato, depression

Janssen’s Spravato (esketamine) nasal spray, derived from the party drug ketamine, has been turned down by NICE for NHS use …

News

“Pharma Bro” Martin Shkreli charged by FTC for price fixing Daraprim

January 28, 2020
Manufacturing and Production FTC, Martin Shkreli, New York Attorney General, Pharma Bro

Martin Shkreli, also known as the “Pharma Bro”, has been charged by the Federal Trade Commission for price fixing. The …

News
mrt_big

FDA approves MS drug for human trials

January 27, 2020
Sales and Marketing MS, MS symptoms, MS treatment, Neuro, neurology

A drug that can make it easier to diagnose Multiple Sclerosis (MS) has been approved for its first human trials …

News
lynn_taylor_updated_headshot_web

Realising the potential of greater collaboration for women living with cancer

January 27, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Merck KGaA, feature, pharma, women

Following the launch of a new global report, ‘Supporting women with cancer’, Lynn Talyroe, Senior Vice President, Head of Healthcare …

Feature

NICE refuses Novo Nordisk’s obesity therapy Saxenda for NHS use

January 27, 2020
Sales and Marketing NHS, NICE, Novo Nordisk, UK, obesity, saxenda

NICE, the drug watchdog for England and Wales, has revealed that it has chosen not to recommend Novo Nordisk’s Saxenda …

News
woman-wearing-mouth-mask

Chinese coronavirus spread is accelerating as Xi Jinping labels it a “grave situation”

January 27, 2020
Sales and Marketing Chinese Coronavrius, MARS, Sars, Viral pnemonia, respiration

The spread of the Chinese coronavirus is accelerating, as multiple countries set up checks and tests to contain the virus. …

News

FDA greenlights its first therapy for advanced epithelioid sarcoma population

January 27, 2020
Sales and Marketing Cancer, Epizyme, FDA, Tazverik, pharma

The FDA has revealed the approval of its first therapy for the treatment of metastatic or locally advanced epithelioid sarcoma, …

News
920x920

Judge overseeing Purdue Pharma bankruptcy approves $1.3 million bonus for CEO

January 27, 2020
Sales and Marketing Election 2020, OxyContin, Purdue Pharma, US Presidential Race, fentanyl, opioid crisis

Purdue Pharma’s CEO Craig Landau can receive a $1.3 million bonus, ruled a judge. Judge Robert Drain said the company …

News
top_10_image_43

Top Ten most popular articles on Pharmafile.com this week

January 24, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Indian pharmaceutical firms received more than double the amount of warning letters in the first ten months of 2019, compared …

News
janssen_latest_logo_on_sign_closer

European Commission expands Stelara for paediatric moderate to severe plaque psoriasis

January 24, 2020
Research and Development Europe, Janssen, Stelara, pharma

Janssen’s Stelara (ustekinumab) has seen its label expanded in Europe to include the treatment of moderate to severe plaque psoriasis …

News
chandler-01

FDA puts MDMA therapy for PTSD on its Expanded Access program

January 24, 2020
Medical Communications Expanded Access, MAPS, MDMA, PTSD, pharmaceuticals, psychedelics, war

The FDA has made MDMA treatment for PTSD more accessible by putting it on the Expanded Access program. 10 sites …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026